Log in to save to my catalogue

Decreased cerebrospinal fluid orexin levels not associated with clinical sleep disturbance in Parkin...

Decreased cerebrospinal fluid orexin levels not associated with clinical sleep disturbance in Parkin...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_plos_journals_2759699871

Decreased cerebrospinal fluid orexin levels not associated with clinical sleep disturbance in Parkinson's disease: A retrospective study

About this item

Full title

Decreased cerebrospinal fluid orexin levels not associated with clinical sleep disturbance in Parkinson's disease: A retrospective study

Publisher

United States: Public Library of Science

Journal title

PloS one, 2022-12, Vol.17 (12), p.e0279747-e0279747

Language

English

Formats

Publication information

Publisher

United States: Public Library of Science

More information

Scope and Contents

Contents

Patients with Parkinson's disease (PD) often suffer from sleep disturbances, including excessive daytime sleepiness (EDS) and rapid eye movement sleep behavior disorder (RBD). These symptoms are also experienced by patients with narcolepsy, which is characterized by orexin neuronal loss. In PD, a decrease in orexin neurons is observed pathologicall...

Alternative Titles

Full title

Decreased cerebrospinal fluid orexin levels not associated with clinical sleep disturbance in Parkinson's disease: A retrospective study

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_plos_journals_2759699871

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_plos_journals_2759699871

Other Identifiers

ISSN

1932-6203

E-ISSN

1932-6203

DOI

10.1371/journal.pone.0279747

How to access this item